Document is current
Any future updates will be listed below
-
Authors
Zhang, Yi https://orcid.org/0000-0003-3419-2461
Shen, Lei
Ren, Lili https://orcid.org/0009-0002-3588-7214
Wei, Jiangbo
Pham, Hoang Quoc Hai https://orcid.org/0000-0002-9044-5008
Tao, Xiaoqun
Guo, Jiamin https://orcid.org/0000-0002-8441-1266
Wang, Zhihao
Shen, Binghui https://orcid.org/0000-0002-4408-407X
Su, Rui
He, Chuan https://orcid.org/0000-0003-4319-7424
Yang, Yanzhong https://orcid.org/0000-0002-1937-4526
-
Funding
Funding for this research was provided by:
HHS | NIH | National Institute of General Medical Sciences (R01GM133850, R35GM156316)
HHS | NIH | National Institute of Neurological Disorders and Stroke (R01NS132083)
HHS | NIH | National Human Genome Research Institute (RM1HG008935)
- License Information
-
More Information
Article History
Received: 7 February 2025
Revised: 15 September 2025
Accepted: 23 September 2025
First Online: 6 October 2025
Disclosure and competing interests statement
: CH is a scientific founder, a member of the scientific advisory board and equity holder of Aferna Bio and Ellis Bio, a scientific cofounder and equity holder of Accent Therapeutics, and a member of the scientific advisory board of Rona Therapeutics and Element Biosciences. The remaining authors declare no competing interests.
